4.3 Article

Contemporary Trends and Efficacy of Pelvic Lymph Node Dissection at Radical Cystectomy for Urothelial and Variant Histology Carcinoma of the Urinary Bladder

期刊

CLINICAL GENITOURINARY CANCER
卷 20, 期 2, 页码 -

出版社

CIG MEDIA GROUP, LP
DOI: 10.1016/j.clgc.2021.10.010

关键词

Bladder cancer; Squamous cell carcinoma; Adenocarcinoma; Neuroendocrine carcinoma; Number of nodes removed; Extended lymph node dissection; extensive lymph node dissection; annual treatment rates

向作者/读者索取更多资源

Contemporary pelvic lymph node dissection rates at radical cystectomy have increased in VHBC and UCUB patients, with potential survival benefits seen in UCUB but not in VHBC. Rates of lymph node invasion slightly increased with the extent of lymph node dissection.
Contemporary pelvic lymph node dissection (PLND) rates at radical cystectomy increased over time in variant histology bladder cancer (VHBC) and urothelial carcinoma of the urinary bladder (UCUB) patients. A potential survival benefit related to more extensive PLND is operational in UCUB patients, but not in VHBC patients. Rates of lymph node invasion increased slightly with extent of PLND. Objective: To test 1) contemporary pelvic lymph node dissection (PLND) trends at radical cystectomy (RC) in variant histology bladder cancer (VHBC) patients and urothelial carcinoma of the urinary bladder (UCUB), as well as 2) to test the effect of PLND extent on cancer specific mortality (CSM) after RC. Methods: Within the Surveillance, Epidemiology and End Results Registry (SEER, 2004-2016), we identified non-metastatic stage T1-2 or T3-4 VHBC and UCUB patients, who underwent RC. CSM and lymph node invasion (LNI) rates were stratified according to PLND extent, as well as coded continuously in multivariate Cox and logistic regression models. Results: Of 19,020 patients, 1736 (9.1%) were coded as having VHBC (46.9% squamous cell carcinoma, 22.5% adenocarcinoma, 18.9% neuroendocrine carcinoma, 11.7% not otherwise specified) vs 17,284 (90.9%) UCUB. PLND was performed in 80.1 of VHBC vs. 83.5% UCUB patients. In both histological groups, PLND rates increased over time (70.9-89.6% and 76.2%-90.1%, both P < .01). PLND extent did not significantly affect CSM in stage T1-2 or T3-4 VHBC patients. Conversely, PLND extent was associated with lower CSM in T1-2, as well as in T3-4 UCUB patients, which was confirmed in multivariate Cox analyses (Hazard ratio [HR] 0.99, P < .001). Rates of LNI increased with extent of PLND in logistic regression analyses in stage T3-4 VHBC (Odds ratio [OR] 1.01, P = .001), stage T1-2 UCUB (OR 1.01, P < .001) and T3-4 UCUB (OR 1.01, P < .001), but not in stage T1-2 VHBC (OR 1.01, P = .3). Conclusion: PLND rates do not differ between VHBC and UCUB patients. A potential survival benefit related to more extensive PLND is operational in UCUB patients, but not in VHBC patients. (C) 2021 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据